N Pozet

1.4k total citations
86 papers, 1.1k citations indexed

About

N Pozet is a scholar working on Nephrology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, N Pozet has authored 86 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 14 papers in Pharmacology and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in N Pozet's work include Blood Pressure and Hypertension Studies (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Renal function and acid-base balance (7 papers). N Pozet is often cited by papers focused on Blood Pressure and Hypertension Studies (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Renal function and acid-base balance (7 papers). N Pozet collaborates with scholars based in France, Switzerland and United Kingdom. N Pozet's co-authors include M Labeeuw, P Zech, Aoumeur Hadj‐Aïssa, J Sassard, P Zech, Claire Pouteil‐Noble, Cécile Couchoud, Martine Laville, J Traeger and Maurice Laville and has published in prestigious journals such as New England Journal of Medicine, Kidney International and The American Journal of Medicine.

In The Last Decade

N Pozet

83 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N Pozet France 20 275 259 199 176 163 86 1.1k
John A. Opsahl United States 17 457 1.7× 228 0.9× 206 1.0× 197 1.1× 189 1.2× 48 1.1k
Gopal Krishna United States 17 273 1.0× 216 0.8× 279 1.4× 177 1.0× 75 0.5× 77 1.2k
Peter U. Feig United States 18 227 0.8× 392 1.5× 346 1.7× 165 0.9× 121 0.7× 30 1.5k
K. H. Rahn Germany 18 603 2.2× 151 0.6× 231 1.2× 172 1.0× 58 0.4× 56 1.2k
John D. Wallin United States 24 452 1.6× 318 1.2× 117 0.6× 287 1.6× 108 0.7× 67 1.7k
Charles Swartz United States 25 599 2.2× 532 2.1× 422 2.1× 327 1.9× 96 0.6× 73 1.8k
Eva Steiness Denmark 20 478 1.7× 66 0.3× 250 1.3× 102 0.6× 166 1.0× 75 1.3k
Robert M. Stote United States 14 80 0.3× 148 0.6× 118 0.6× 107 0.6× 130 0.8× 25 702
J G Gerber United States 20 237 0.9× 100 0.4× 157 0.8× 116 0.7× 281 1.7× 47 1.2k
A. E. Doyle Australia 19 494 1.8× 173 0.7× 119 0.6× 186 1.1× 112 0.7× 76 1.3k

Countries citing papers authored by N Pozet

Since Specialization
Citations

This map shows the geographic impact of N Pozet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Pozet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Pozet more than expected).

Fields of papers citing papers by N Pozet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Pozet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Pozet. The network helps show where N Pozet may publish in the future.

Co-authorship network of co-authors of N Pozet

This figure shows the co-authorship network connecting the top 25 collaborators of N Pozet. A scholar is included among the top collaborators of N Pozet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Pozet. N Pozet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Couchoud, Cécile, N Pozet, M Labeeuw, & Claire Pouteil‐Noble. (1999). Screening early renal failure: Cut-off values for serum creatinine as an indicator of renal impairment. Kidney International. 55(5). 1878–1884. 126 indexed citations
2.
Fauvel, Jean‐Pierre, et al.. (1998). Effects of Moxonidine on Stress-Induced Peak Blood Pressure and Renal Function. Journal of Cardiovascular Pharmacology. 32(3). 495–499. 5 indexed citations
3.
Steghens, Jean‐Paul, et al.. (1997). Nifedipine improves recovery function of kidneys preserved in a high- sodium, low-potassium cold-storage solution: study with the isolated perfused rat kidney technique. Nephrology Dialysis Transplantation. 12(3). 449–455. 15 indexed citations
4.
Pouteil‐Noble, Claire, François Chapuis, S. Bosshard, et al.. (1996). Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trial.. PubMed. 28(5). 2811–2811. 17 indexed citations
5.
Goudable, J., et al.. (1996). Creatinine determination in peritoneal dialysis: what method should be used?. Nephrology Dialysis Transplantation. 11(11). 2282–2287. 9 indexed citations
6.
Fauvel, Jean Pierre, J. M. Cottet-Émard, Martine Laville, et al.. (1995). Spectral Analysis of Stress-Induced Change in Blood Pressure and Heart Rate in Normotensive Subjects. Journal of Cardiovascular Pharmacology. 25(3). 448–452. 20 indexed citations
7.
Hadj-Aïssa, A., Lise Bankir, Daniel G. Bichet, et al.. (1992). Influence of the level of hydration on the renal response to a protein meal. Kidney International. 42(5). 1207–1216. 49 indexed citations
8.
Mercatello, A., Aoumeur Hadj‐Aïssa, Pierre Sagnard, et al.. (1991). Microalbuminuria Is Acutely Increased during Anesthesia and Surgery. ˜The œNephron journals/Nephron journals. 58(2). 161–163. 3 indexed citations
9.
Laville, Maurice, Christophe Doche, Jean‐Pierre Fauvel, et al.. (1990). Effect of Beta-Blockade on Albumin Excretion Rate in Essential Hypertension. ˜The œNephron journals/Nephron journals. 54(2). 183–184. 3 indexed citations
10.
Lecaillon, J. B., et al.. (1990). Pharmacokinetics of oxiracetam in patients with renal impairment after a 800 mg single oral dose. European Journal of Drug Metabolism and Pharmacokinetics. 15(3). 231–237. 3 indexed citations
11.
Bernard, Nicole F., et al.. (1989). The influence of renal insufficiency and haemodialysis on the kinetics of ciprofibrate.. British Journal of Clinical Pharmacology. 28(6). 675–681. 9 indexed citations
12.
Singlas, E, et al.. (1988). Pharmacokinetics of rilmenidine. The American Journal of Cardiology. 61(7). D54–D59. 8 indexed citations
13.
Labeeuw, M, et al.. (1987). [Influence of acute administration of ramipril on the excretion of uric acid].. PubMed. 80(6). 870–4. 6 indexed citations
14.
Folléa, Gilles, Martine Laville, N Pozet, & M Dechavanne. (1986). Pharmacokinetic Studies of Standard Heparin and Low Molecular Weight Heparin in Patients with Chronic Renal Failure. Pathophysiology of Haemostasis and Thrombosis. 16(2). 147–151. 26 indexed citations
15.
Pozet, N, et al.. (1983). Pharmacokinetics of diltiazem in severe renal failure. European Journal of Clinical Pharmacology. 24(5). 635–638. 40 indexed citations
16.
Zech, P, et al.. (1982). Ranitidine kinetics in normal subjects. Clinical Pharmacology & Therapeutics. 31(6). 770–774. 38 indexed citations
17.
Brazier, J. L., et al.. (1982). Kinetics of a high dose of piretanide in renal failure. European Journal of Clinical Pharmacology. 21(4). 307–310. 11 indexed citations
18.
Zech, P, et al.. (1977). [Idiopathic cyclic edema: disorders in water elimination accentuated by orthostasis].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 6(13). 1121–4. 2 indexed citations
19.
Zech, P, N Pozet, M Labeeuw, et al.. (1976). Acute renal effects of new beta-adrenergic receptor site blocking agents on renal function.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 12. 203–9. 8 indexed citations
20.
Traeger, J, P Zech, Bruno François, et al.. (1969). [Arterial hypertension in chronic kidney failure treated by extra-renal dialysis].. PubMed. 261–96. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026